Medicare Part D drug Data year 2024 Brand name Source: CMS Part D Prescribers

Xifaxan

Rifaximin

Open in the dashboard

Part D claims

280,807

Prescriptions dispensed, refills included

Drug cost

$774,417,061

Paid at the pharmacy, in all

Prescribers

10,439

With 11 or more claims of it

In 2024, Medicare Part D recorded 280,807 claims for Xifaxan (rifaximin) from 10,439 prescribers, at a total drug cost of $774.4 million paid at the pharmacy by Medicare, patients and others.

Where it is prescribed

By the prescriber's state · 53 states and territories
Part D claims for Xifaxan by the state of the prescriber, 2024
State Relative to the most Prescribers Claims Drug cost
TX 837 29,682 $86,696,680
CA 1,103 27,579 $76,595,868
NY 846 20,969 $57,913,899
FL 651 17,509 $48,090,201
PA 493 12,773 $33,979,739
OH 448 12,628 $32,979,126
NC 380 9,427 $26,527,412
KY 295 9,291 $25,633,047
TN 291 9,091 $24,793,452
MA 325 8,805 $22,230,336
IL 311 7,851 $21,057,775
GA 287 7,663 $21,056,188
IN 261 7,488 $19,959,014
MI 274 7,449 $19,728,514
NJ 281 7,257 $19,359,084
The other 38 states and territories
State Prescribers Claims Drug cost
MO 223 6,384 $17,452,759
VA 220 5,402 $13,928,139
SC 163 5,349 $14,258,491
CT 183 4,814 $12,508,261
AL 152 4,713 $12,893,383
CO 181 4,330 $12,187,926
WI 157 4,204 $12,366,293
AZ 161 4,162 $12,913,815
WA 178 4,006 $12,100,657
LA 138 3,610 $9,873,931
MD 163 3,514 $8,692,893
MN 142 3,234 $9,336,850
OK 112 3,126 $9,143,086
WV 96 2,910 $7,133,588
OR 126 2,706 $8,160,844
KS 91 2,478 $7,131,287
MS 92 2,268 $5,706,139
AR 87 2,229 $6,370,235
IA 75 2,133 $5,882,230
NE 56 1,293 $3,975,208
ME 53 1,250 $3,828,676
NM 55 1,235 $3,542,636
UT 53 1,197 $3,675,454
RI 46 1,106 $2,785,350
ID 50 1,052 $3,136,429
NH 41 1,042 $3,073,094
DE 32 944 $2,419,538
MT 49 858 $2,173,160
NV 35 785 $2,442,672
SD 27 588 $1,688,048
PR 24 501 $1,562,667
ND 24 493 $1,302,831
VT 21 363 $992,045
DC 15 335 $1,161,867
AK 11 282 $730,664
HI 17 278 $906,300
WY 6 137 $271,404
XX 1 34 $107,875

The state is where the prescriber practices, not where the patient lives. Totals are Medicare Part D claims only.

Which specialties prescribe it

Top 15 of 45
Part D claims for Xifaxan by prescriber specialty, 2024
Specialty Relative to the most Prescribers Claims Drug cost
Gastroenterology 3,274 94,178 $295,256,017
Internal Medicine 2,178 55,299 $123,831,254
Nurse Practitioner 2,000 55,156 $162,447,319
Family Practice 1,531 32,115 $68,730,673
Physician Assistant 938 30,609 $94,542,605
Geriatric Medicine 91 2,706 $4,445,036
Hospitalist 78 1,972 $3,389,462
General Practice 57 1,150 $2,243,689
Infectious Disease 33 1,116 $3,302,211
Emergency Medicine 40 1,001 $1,686,396
Undefined Physician type 9 908 $2,951,063
General Surgery 22 771 $2,259,760
Nephrology 17 385 $823,828
Hospice and Palliative Care 15 373 $699,178
Student in an Organized Health Care Education/Training Program 26 351 $1,200,430

Specialty is the one printed on each prescriber's Medicare claims.

Largest prescribers

First 5 of 100 by claims · 2024

Two separate records. Claims come from Medicare and related payments from Open Payments. They are shown in one row because they name the same product; they do not show that a payment affected a prescription.

The prescribers with the most Part D claims of this drug in 2024
Prescriber Specialty State Claims Drug cost Related payments
Tram Pham Physician Assistant TX 3,713 $12,010,412 No profile
Amanda Matthews Physician Assistant TX 600 $1,891,637 None on record
Macy Godman Physician Assistant KY 481 $1,554,632 None on record
Miguel Malespin Gastroenterology FL 480 $1,508,519 None on record
Kimberly Akinyele Nurse Practitioner TN 451 $1,420,502 None on record

"No profile" means the prescriber has no Open Payments record here; "None on record" means no payment naming this product in the payment year. Related payments are general payments, and one that names several products is split evenly, so an amount is payments related to the product, not money paid for it. The list is the prescribers with the most claims, up to 100 per drug.

See more in the dashboard: 25 with a free account, all 100 with Patron

Industry payments naming this drug

From CMS Open Payments

Open Payments names products as manufacturers reported them, and CMS does not link them to Part D drugs, so this match is by name and ours. The two records are separate: they do not show that a payment affected a prescription.

What this means

Medicare Part D is the part of Medicare that covers prescription drugs dispensed at a pharmacy. Each year CMS publishes, for every prescriber and drug, how many claims were dispensed and what they cost. This page adds those up for one drug.

A claim is one prescription filled, refills included. Drug cost is the total paid at the pharmacy by Medicare, the patient and anyone else; it is not money to the prescriber. CMS leaves out any prescriber with fewer than 11 claims of a drug, so the prescriber count is a floor and a missing prescriber does not mean none.

Part D covers drugs dispensed to Medicare beneficiaries at a pharmacy. It does not include drugs given in a clinic or hospital, patients with other insurance, or the most recent year, which Medicare publishes about two years behind.

Provenance

Source: CMS Medicare Part D Prescribers by Provider and Drug · data year 2024

We reproduce what CMS published. We do not verify, edit or correct the underlying records.

A prescription record is not evidence of wrongdoing, and nothing here is medical advice. Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency.

How to dispute or correct a record